Researchers Submit Patent Application, "Methods Of Isolating T Cells And T Cell Receptors Having Antigenic Specificity For A Cancer-Specific Mutation From Peripheral Blood", for Approval (USPTO 20230303976).
In: Cancer Weekly, 2023-10-17, S. 1757
serialPeriodical
Zugriff:
The method of claim 1, wherein inducing autologous APCs of the patient to present the mutated amino acid sequence comprises introducing a nucleotide sequence encoding the mutated amino acid sequence into the APCs. The method of claim 6, wherein the nucleotide sequence introduced into the autologous APCs is a tandem minigene (TMG) construct, each minigene comprising a different gene, each gene including a cancer-specific mutation that encodes a mutated amino acid sequence. [Extracted from the article]
Copyright of Cancer Weekly is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
Researchers Submit Patent Application, "Methods Of Isolating T Cells And T Cell Receptors Having Antigenic Specificity For A Cancer-Specific Mutation From Peripheral Blood", for Approval (USPTO 20230303976).
|
---|---|
Zeitschrift: | Cancer Weekly, 2023-10-17, S. 1757 |
Veröffentlichung: | 2023 |
Medientyp: | serialPeriodical |
ISSN: | 1071-7218 (print) |
Sonstiges: |
|